Aurora Cannabis, Inc. (NASDAQ: ACB) on Wednesday reported a net loss for the third quarter of 2023. The company’s revenues moved up 27% year-over-year during the quarter.
The Canada-based medical marijuana company reported a net loss of C$87 million for the third quarter. Adjusted EBITDA was C$0.31 million during the three-month period, compared to a loss of C$10.03 million in the prior-year quarter. Total revenues increased 27% annually to C$64 million.
“Over the last three years, our ongoing business transformation initiatives have delivered ~$400 million in annualized cost savings that have significantly reduced cash used in operating activities. In fact, cash use continues to improve as evidenced by the reduction from $35.5 million in Q2 2023 to $15.1 million in Q3 2023, excluding working capital,” said Miguel Martin, chief executive officer of Aurora Cannabis.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Nike, Inc. (NYSE: NKE) on Thursday reported results for the first three months of fiscal 2024, reporting a modest rise in revenues. The sneaker giant reported net income of $1.45
Shares of Accenture plc (NYSE: ACN) were down 4% on Thursday after the company delivered mixed results for the fourth quarter of 2023 and provided full-year guidance that came below
CarMax, Inc. (NYSE: KMX) reported second quarter 2024 earnings results today. Net revenues were $7.1 billion, down 13.1% compared to the same period a year ago. Net earnings declined 5.8%